0521779407-10 CUNY1086/Karliner 0 521 77940 7 June 7, 2007 18:40
Infective Endocarditis 829
Infective Endocarditis.................................
RICHARD A. JACOBS, MD, PhD
history & physical
History
■Usually, but not always (ie, IV drug users), an underlying abnormality
predisposing to infection – valvular disease (rheumatic heart disease,
mitral valve prolapse), damage to endothelium from regurgitant jet
flow or congenital abnormalities (VSD, patent ductus)
■Etiology depends on clinical setting: Native valve endocarditis due
to viridans streptococci, S. aureus and enterococci; prosthetic valve
endocarditis within 2 months of surgery (early infection) due to
S. epidermidis (and other coagulase-negative staphylococci), S.
aureus, Gram negative bacilli; late infections (greater than 2 months
post-operatively) similar to native valve endocarditis; endocarditis
in IV drug users caused predominantly by S. aureus; culture nega-
tive endocarditis due to previous administration of antibiotics, fungi
(blood cultures positive in only 50% of cases), slow growing organ-
isms such as the HACEK organisms and Brucella, organisms that
require special media for growth such as Legionella, Bartonella, and
nutritionally variant streptococci, and organisms that do not grow
on conventional media such as Coxiella burnetii (Q fever)
Signs & Symptoms
■Virulent organisms (S. aureus) usually present acutely with rapidly
progressive infection, tissue destruction and systemic emboli,
although more indolent presentation (especially IV drug users with
tricuspid infection) can occur; less virulent organisms (streptococci,
enterococci, fungi, HACEK organisms)present most often with a sub-
acute course
■Presenting symptoms often nonspecific – fever, chills, malaise,
arthralgias, back pain; peripheral embolization manifest as stroke or
abdominal pain (splenic embolization); fever (90%), heart murmur
(80–90%), splenomegaly (40%) and peripheral manifestations such
as petechiae, splinter hemorrhages, Osler nodes, Janeway lesions
and Roth spots occur in 10–40%
tests
■Elevated WBCs in acute disease; anemia with subacute disease;
hematuria from embolization to kidneys or immune-mediated